PAPER Liu DX, Greene LA

Regulation of neuronal survival and death by E2F-dependent gene repression and derepression.

Neuron. 2001 Nov 8;32(3):425-38. PubMed.

PAPER Croom J, Taylor IL

Neuropeptide Y, peptide YY and aluminum in Alzheimer's disease: is there an etiological relationship?

J Inorg Biochem. 2001 Nov;87(1-2):51-6. PubMed.

PAPER Canales JJ, Corbalán R, Montoliu C, Llansola M, Monfort P, Erceg S, Hernandez-Viadel M, Felipo V

Aluminium impairs the glutamate-nitric oxide-cGMP pathway in cultured neurons and in rat brain in vivo: molecular mechanisms and implications for neuropathology.

J Inorg Biochem. 2001 Nov;87(1-2):63-9. PubMed.

PAPER Niwa K, Porter VA, Kazama K, Cornfield D, Carlson GA, Iadecola C

A beta-peptides enhance vasoconstriction in cerebral circulation.

Am J Physiol Heart Circ Physiol. 2001 Dec;281(6):H2417-24. PubMed.

PAPER Athan ES, Williamson J, Ciappa A, Santana V, Romas SN, Lee JH, Rondon H, Lantigua RA, Medrano M, Torres M, Arawaka S, Rogaeva E, Song YQ, Sato C, Kawarai T, Fafel KC, Boss MA, Seltzer WK, Stern Y, St George-Hyslop P, Tycko B, Mayeux R

A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families.

JAMA. 2001 Nov 14;286(18):2257-63. PubMed.

PAPER Beyer K, Lao JI, Gómez M, Riutort N, Latorre P, Mate JL, Ariza A

Alzheimer's disease and the cystatin C gene polymorphism: an association study.

Neurosci Lett. 2001 Nov 23;315(1-2):17-20. PubMed.

PAPER Brunelli T, Bagnoli S, Giusti B, Nacmias B, Pepe G, Sorbi S, Abbate R

The C677T methylenetetrahydrofolate reductase mutation is not associated with Alzheimer's disease.

Neurosci Lett. 2001 Nov 23;315(1-2):103-5. PubMed.

PAPER Zhuang ZP, Kung MP, Hou C, Plössl K, Skovronsky D, Gur TL, Trojanowski JQ, Lee VM, Kung HF

IBOX(2-(4'-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain.

Nucl Med Biol. 2001 Nov;28(8):887-94. PubMed.

PAPER Maurage CA, Sergeant N, Ruchoux MM, Hauw JJ, Delacourte A

Paradoxical phosphorylation of the serine 199 on tau proteins from young individuals.

Neuroreport. 2001 Oct 29;12(15):3177-81. PubMed.

PAPER Poduslo JF, Curran GL

Amyloid beta peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier.

Neuroreport. 2001 Oct 29;12(15):3197-200. PubMed.

PAPER Thomas T, Nadackal TG, Thomas K

Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation.

Neuroreport. 2001 Oct 29;12(15):3263-7. PubMed.

PAPER Laitinen KS, van Groen T, Tanila H, Venäläinen J, Männistö PT, Alafuzoff I

Brain prolyl oligopeptidase activity is associated with neuronal damage rather than beta-amyloid accumulation.

Neuroreport. 2001 Oct 29;12(15):3309-12. PubMed.

PAPER Presente A, Andres A, Nye JS

Requirement of Notch in adulthood for neurological function and longevity.

Neuroreport. 2001 Oct 29;12(15):3321-5. PubMed.

PAPER Nicolaou M, Song YQ, Sato CA, Orlacchio A, Kawarai T, Medeiros H, Liang Y, Sorbi S, Richard E, Rogaev EI, Moliaka Y, Bruni AC, Jorge R, Percy M, Duara R, Farrer LA, St Georg-Hyslop P, Rogaeva EA

Mutations in the open reading frame of the beta-site APP cleaving enzyme (BACE) locus are not a common cause of Alzheimer's disease.

Neurogenetics. 2001 Oct;3(4):203-6. PubMed.

PAPER Frederiks JA

Alzheimer's Disease and Related Disorders Annual 2001, Edited by S. Gauthier and J.L. Cummings, Martin Dunitz, London, 2001, 216 pp., ISBN 1-84184-022-X.

Clin Neurol Neurosurg. 2001 Dec;103(4):265. PubMed.